Revised MRPs of 1,364 anti-cancer formulations come into effect; consumers to save ₹3,540 crore/year

According to the Ministry, 85 pharmaceutical companies have reported revised MRPs for 1,364 anti-cancer formulations across 121 drugs as of November 8, 2026
Read the full story on The Hindu Opens thehindu.com in a new tab
Advertisement
OZYNIXCRM, HRMS & Business ToolsAI-powered business software — early access openContact us
This is a short summary of a story published by The Hindu, shown with a link to the original. The full story, photo and reporting belong to The Hindu.












